Articles

Find an Article

Filter articles

Applied Filters

Showing 31 to 39 of 39 results

Drug price regulation in Brazil: Roche faces IP rights abuse claims

Brazil02-08-2016Anderson Ribeiro and Ricardo Campello

The Brazilian Federal Prosecutor’s Office has taken court action against Roche for allegedly abusing IP rights in its sales of Herceptin to state governments. Anderson Ribeiro and Ricardo Campello of Provedel Advogados analyse the case.

Brexit and IP: business as usual, for now

EU, UK07-07-2016Claire Phipps-Jones

Following the UK’s vote to leave the EU, it is business as usual for life sciences companies working with intellectual property, at least for now, says Claire Phipps-Jones of Bristows.

Freeing Africa from hunger

Kenya08-06-2016

Africa Harvest is working towards reducing hunger and poverty in some of the world’s poorest countries. Dr Florence Wambugu, founder of the organisation, tells LSIPR more about its work.

Biotech in Birmingham: Alta Innovations’ story

UK05-06-2016

Birmingham—Britain’s second city—with a leading university for research and development, allows biotech companies to enjoy the benefits of a cluster, as James Wilkie, CEO of Alta Innovations, the commercial spinout of the University of Birmingham, told LSIPR.

A sense of relief: enforcing second medical use patents

UK31-03-2016Katie Hutchinson

Owners of second medical use patents may need to think outside the box in terms of the relief they seek for infringement, says Katie Hutchinson of Bristows.

Europe v US: the patentability of diagnostic claims

EU, US17-09-2015Andrew Carridge and Neil Thornton

Researchers should keep in mind that broad claims applying the discovery of a biomarker and disease correlation are currently patentable in Europe but not in the US. Andrew Carridge and Neil Thornton of Reddie & Grose report.

Patent portfolios: maximise the value and minimise the cost

UK06-08-2015Bruno Reynolds

Proactively managing patent portfolios is an investment that pays for itself in reduced patent costs. Bruno Reynolds, who works at the consultancy arm of Isis Innovation, the technology transfer company of the University of Oxford, explains more.

Partnering for profit

Brazil16-07-2015

Despite its troubled start, Brazil’s Product Development Partnerships programme is now entering a new stage of its development with the introduction of a more complete system for regulation, but there’s also more scope for patent infringement, say Otto Licks and Ricardo Campello of Licks Attorneys.

IP in Australia: major changes in store

Australia21-05-2015

February’s amendments to the Australian IP Act seek to increase the effectiveness and efficiency of the country’s IP system. LSIPR takes a look at the major changes and considers who will benefit most in the life sciences sector.

Showing 31 to 39 of 39 results

LSIPR